2. THE PRINCIPLES OF ICH GCP, INTEGRATED ADDENDUM TO ICH E6(R1): GUIDELINE FOR GOOD CLINICAL PRACTICE ICH E6(R2)
2.1 Clinical trials should be conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki, and that are consistent with GCP and the applicable regulatory requirement(s).
2.2 Before a trial is initiated, foreseeable risks and inconveniences should be weighed against the anticipated benefit for the individual trial subject and society. A trial should be initiated and continued only if the anticipated benefits justify the risks.
2.3 The rights, safety, and well-being of the trial subjects are the most important considerations and should prevail over interests of science and society.
2.4 The available nonclinical and clinical information on an investigational product should be adequate to support the proposed clinical trial.
2.5 Clinical trials should be scientifically sound, and described in a clear, detailed protocol.
2.6 A trial should be conducted in compliance with the protocol that has received prior institutional review board (IRB)/independent ethics committee (IEC) approval/favourable opinion.
2.7 The medical care given to, and medical decisions made on behalf of, subjects should always be the responsibility of a qualified physician or, when appropriate, of a qualified dentist.
2.8 Each individual involved in conducting a trial should be qualified by education, training, and experience to perform his or her respective task(s).
2.9 Freely given informed consent should be obtained from every subject prior to clinical trial participation.
2.10 All clinical trial information should be recorded, handled, and stored in a way that allows its accurate reporting, interpretation and verification.
ADDENDUM
This principle applies to all records referenced in this guideline, irrespective of the type of media used.
2.11 The confidentiality of records that could identify subjects should be protected, respecting the privacy and confidentiality rules in accordance with the applicable regulatory requirement(s).
2.12 Investigational products should be manufactured, handled, and stored in accordance with applicable good manufacturing practice (GMP). They should be used in accordance with the approved protocol.
2.13 Systems with procedures that assure the quality of every aspect of the trial should be implemented.
ADDENDUM
Aspects of the trial that are essential to ensure human subject protection and reliability of trial results should be the focus of such systems.
Author: © European Medicines Agency, 2018.
Clinical Research News
Upcoming Clinical Research Events
-
26 – 28 September 2023
Fierce Pharma
United States -
29 September – 01 October 2023
SOCRA (Society of Clinical Research Associates) -
Canada -
08 – 11 October 2023
TransCelerate BioPharma
United States -
08 – 11 October 2023
SCDM (Society of Clinical Data Management)
United States -
16 – 17 October 2023
The Conference Forum
United States -
17 – 18 October 2023
Cambridge Innovation Institute
Spain -
01 – 03 November 2023
RQA (Research Quality Association)
United Kingdom -
11 – 15 November 2023
AMIA (American Medical Informatics Association)
United States -
15 – 16 November 2023
World BI
United States -
29 – 30 November 2023
Informa
Spain
Upcoming Clinical Trials
-
NCT06050070Not yet recruiting
-
NCT06049199Not yet recruitingListening Effort
-
NCT06050811Not yet recruiting
-
NCT06049576RecruitingClear Cell Renal Cell Carcinoma | Stage III Renal Cell Cancer AJCC v8 | Stage IV Renal Cell Cancer AJCC v8 | Sarcomatoid Renal Cell Carcinoma
-
NCT06050434Not yet recruiting
-
NCT06050057RecruitingCushing Syndrome | Pheochromocytoma | Adrenocortical Carcinoma | Adrenal Cortex Diseases | Adrenocortical Adenoma | Adrenal Tumor | Adrenalectomy; Status | Adrenal Mass | Adrenal Hyperplasia | Adrenal Disease
-
NCT06051240Not yet recruitingCognitive Impairment | Brain Tumor | Cognitive Decline | Memory Impairment | Radiotherapy Side Effect | Radiotherapy; Complications | Late Effect of Radiation
-
NCT06050928Recruiting
-
NCT06049784Not yet recruitingObstetric Labor Complications | Obstetric Trauma
-
NCT06049498Not yet recruiting
-
NCT06049381Not yet recruitingRelapsed Non-Hodgkin Lymphoma
-
NCT06051435RecruitingPrimary Dysmenorrhea